Details
Stereochemistry | ACHIRAL |
Molecular Formula | C6H11N3 |
Molecular Weight | 125.1716 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CNCCC1=CN=CN1
InChI
InChIKey=PHSPJQZRQAJPPF-UHFFFAOYSA-N
InChI=1S/C6H11N3/c1-7-3-2-6-4-8-5-9-6/h4-5,7H,2-3H2,1H3,(H,8,9)
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/24534036
Sources: https://www.ncbi.nlm.nih.gov/pubmed/24534036
alpha-N-methyl-histamine is a metabolite of histamine that plays an important role in several (patho) physiological processes. alpha-N-methyl-histamine is being a potent agonist of histamine H3 receptor can be used as an effective therapeutic alternative in migraine patients.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: Q9QYN8 Gene ID: 85268.0 Gene Symbol: Hrh3 Target Organism: Rattus norvegicus (Rat) Sources: https://www.ncbi.nlm.nih.gov/pubmed/2161226 |
0.4 nM [Kd] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Preventing | Unknown Approved UseUnknown |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/24534036
in migraine prophylaxis: 1 to 3 ug twice a week
Route of Administration:
Other
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2161226
Unknown
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
LOINC |
34345-9
Created by
admin on Fri Dec 15 17:59:44 GMT 2023 , Edited by admin on Fri Dec 15 17:59:44 GMT 2023
|
||
|
LOINC |
26053-9
Created by
admin on Fri Dec 15 17:59:44 GMT 2023 , Edited by admin on Fri Dec 15 17:59:44 GMT 2023
|
||
|
LOINC |
44340-8
Created by
admin on Fri Dec 15 17:59:44 GMT 2023 , Edited by admin on Fri Dec 15 17:59:44 GMT 2023
|
||
|
LOINC |
34344-2
Created by
admin on Fri Dec 15 17:59:44 GMT 2023 , Edited by admin on Fri Dec 15 17:59:44 GMT 2023
|
||
|
LOINC |
13781-0
Created by
admin on Fri Dec 15 17:59:44 GMT 2023 , Edited by admin on Fri Dec 15 17:59:44 GMT 2023
|
||
|
LOINC |
34346-7
Created by
admin on Fri Dec 15 17:59:44 GMT 2023 , Edited by admin on Fri Dec 15 17:59:44 GMT 2023
|
||
|
LOINC |
12714-2
Created by
admin on Fri Dec 15 17:59:44 GMT 2023 , Edited by admin on Fri Dec 15 17:59:44 GMT 2023
|
||
|
LOINC |
80152-2
Created by
admin on Fri Dec 15 17:59:44 GMT 2023 , Edited by admin on Fri Dec 15 17:59:44 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
Y7QR253130
Created by
admin on Fri Dec 15 17:59:44 GMT 2023 , Edited by admin on Fri Dec 15 17:59:44 GMT 2023
|
PRIMARY | |||
|
912
Created by
admin on Fri Dec 15 17:59:44 GMT 2023 , Edited by admin on Fri Dec 15 17:59:44 GMT 2023
|
PRIMARY | |||
|
673-50-7
Created by
admin on Fri Dec 15 17:59:44 GMT 2023 , Edited by admin on Fri Dec 15 17:59:44 GMT 2023
|
PRIMARY | |||
|
DTXSID00217671
Created by
admin on Fri Dec 15 17:59:44 GMT 2023 , Edited by admin on Fri Dec 15 17:59:44 GMT 2023
|
PRIMARY | |||
|
29009
Created by
admin on Fri Dec 15 17:59:44 GMT 2023 , Edited by admin on Fri Dec 15 17:59:44 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD